Niagen Bioscience, Inc. Common Stock

NAGENASDAQUSD
3.17 USD
0.06 (1.93%)AT CLOSE (11:59 AM EDT)
3.17
0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
3.17
0.00 (0.00%)
🔴Market: CLOSED

Shares of Niagen Bioscience, Inc. Common Stock (NAGE) are trading at $3.17. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place NAGE at a fair price relative to peers.

Technical & fundamental data as of Sep 4, 2026.

Open?$3.10
High?$3.17
Low?$3.07
Prev. Close?$3.11
Volume?256.8K
Avg. Volume?581.7K
VWAP?$3.13
Rel. Volume?0.44x
Bid / Ask
Bid?$3.10 × 1.5K
Ask?$3.17 × 500
Spread?$0.07
Midpoint?$3.14
Valuation & Ratios
Market Cap?250.8M
Shares Out?79.6M
Float?51.9M
Float %?65.1%
P/E Ratio?15.69
P/B Ratio?3.04
EPS?$0.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Employees
117
Market Cap
250.8M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed
2008-06-24
Address
10900 WILSHIRE BLVD
LOS ANGELES, CA 90024
Phone: 310-388-6706
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
10
Short Sent.?
65
Piotroski F-Score?3/9Weak
Altman Z-Score?6.66Safe
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.31%Elevated
Short Interest?4.3M
Days to Cover?5.4
Free Float51.9M
Avg Daily Volume805.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?6.50Strong
Quick Ratio?5.13Strong
Cash Ratio?4.43Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
78/100
P/E?
Peers
100
S&P
79
15.7CHEAP
P/B?
Peers
100
S&P
55
3.04FAIR
P/S?
Peers
100
S&P
68
1.94CHEAP
P/FCF?
Peers
100
S&P
14
44.2PRICEY
EV/EBITDA?
Peers
100
S&P
44
15.9FAIR
EV/Sales?
Peers
100
S&P
85
1.43CHEAP
Returns & Efficiency
ROE?
Peers
50
S&P
65
19.4%STRONG
ROA?
Peers
50
S&P
87
15.0%STRONG
Cash Flow & Enterprise
FCF?$5.7M
Enterprise Value?$184.1M
Fundamentals ratios updated end of day